These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


372 related items for PubMed ID: 17335321

  • 1. Melatonin in schizophrenic outpatients with insomnia: a double-blind, placebo-controlled study.
    Suresh Kumar PN, Andrade C, Bhakta SG, Singh NM.
    J Clin Psychiatry; 2007 Feb; 68(2):237-41. PubMed ID: 17335321
    [Abstract] [Full Text] [Related]

  • 2. Melatonin in medically ill patients with insomnia: a double-blind, placebo-controlled study.
    Andrade C, Srihari BS, Reddy KP, Chandramma L.
    J Clin Psychiatry; 2001 Jan; 62(1):41-5. PubMed ID: 11235927
    [Abstract] [Full Text] [Related]

  • 3. Nonorganic insomnia in generalized anxiety disorder. 2. Comparative studies on sleep, awakening, daytime vigilance and anxiety under lorazepam plus diphenhydramine (Somnium) versus lorazepam alone, utilizing clinical, polysomnographic and EEG mapping methods.
    Saletu B, Saletu-Zyhlarz G, Anderer P, Brandstätter N, Frey R, Gruber G, Klösch G, Mandl M, Grünberger J, Linzmayer L.
    Neuropsychobiology; 1997 Jan; 36(3):130-52. PubMed ID: 9313245
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The efficacy and safety of the melatonin agonist beta-methyl-6-chloromelatonin in primary insomnia: a randomized, placebo-controlled, crossover clinical trial.
    Zemlan FP, Mulchahey JJ, Scharf MB, Mayleben DW, Rosenberg R, Lankford A.
    J Clin Psychiatry; 2005 Mar; 66(3):384-90. PubMed ID: 15766306
    [Abstract] [Full Text] [Related]

  • 10. [Controlled release melatonin (Circadin) in the treatment of insomnia in older patients: efficacy and safety in patients with history of use and non-use of hypnotic drugs].
    Zisapel N.
    Harefuah; 2009 May; 148(5):337-41, 348. PubMed ID: 19630367
    [Abstract] [Full Text] [Related]

  • 11. Efficacy and safety of zolpidem-MR: a double-blind, placebo-controlled study in adults with primary insomnia.
    Roth T, Soubrane C, Titeux L, Walsh JK, Zoladult Study Group.
    Sleep Med; 2006 Aug; 7(5):397-406. PubMed ID: 16815744
    [Abstract] [Full Text] [Related]

  • 12. Efficacy of treatment of insomnia in migraineurs with eszopiclone (Lunesta®) and its effect on total sleep time, headache frequency, and daytime functioning: A randomized, double-blind, placebo-controlled, parallel-group, pilot study.
    Spierings EL, McAllister PJ, Bilchik TR.
    Cranio; 2015 Apr; 33(2):115-21. PubMed ID: 25323219
    [Abstract] [Full Text] [Related]

  • 13. Esmirtazapine in non-elderly adult patients with primary insomnia: efficacy and safety from a 2-week randomized outpatient trial.
    Ivgy-May N, Roth T, Ruwe F, Walsh J.
    Sleep Med; 2015 Jul; 16(7):831-7. PubMed ID: 26047890
    [Abstract] [Full Text] [Related]

  • 14. [Melatonin--a natural hypnotic?].
    Saletu B.
    Wien Klin Wochenschr; 1997 Oct 03; 109(18):714-21. PubMed ID: 9441514
    [Abstract] [Full Text] [Related]

  • 15. Sustained efficacy of eszopiclone over 6 months of nightly treatment: results of a randomized, double-blind, placebo-controlled study in adults with chronic insomnia.
    Krystal AD, Walsh JK, Laska E, Caron J, Amato DA, Wessel TC, Roth T.
    Sleep; 2003 Nov 01; 26(7):793-9. PubMed ID: 14655910
    [Abstract] [Full Text] [Related]

  • 16. Temazepam or Melatonin Versus Placebo for the Treatment of Insomnia in Advanced Cancer: A Three-Arm, Double-Blind, Phase III, Multicenter, Randomized Clinical Trial.
    Mendis R, Wong A, Frenkel S, Southcott AM, Selman CJ, Martin J, Grobler A, Currow D, Agar M, Le B, Philip J.
    J Palliat Med; 2024 Oct 01; 27(10):1368-1373. PubMed ID: 39304187
    [Abstract] [Full Text] [Related]

  • 17. Zolpidem in the treatment of transient insomnia: a double-blind, randomized comparison with placebo.
    Roth T, Roehrs T, Vogel G.
    Sleep; 1995 May 01; 18(4):246-51. PubMed ID: 7618022
    [Abstract] [Full Text] [Related]

  • 18. Treatment of elderly primary insomnia patients with EVT 201 improves sleep initiation, sleep maintenance, and daytime sleepiness.
    Walsh JK, Salkeld L, Knowles LJ, Tasker T, Hunneyball IM.
    Sleep Med; 2010 Jan 01; 11(1):23-30. PubMed ID: 19945340
    [Abstract] [Full Text] [Related]

  • 19. Sleep laboratory investigations on hypnotic properties of melatonin.
    Waldhauser F, Saletu B, Trinchard-Lugan I.
    Psychopharmacology (Berl); 1990 Jan 01; 100(2):222-6. PubMed ID: 2305009
    [Abstract] [Full Text] [Related]

  • 20. Controlled-release melatonin, singly and combined with cognitive behavioural therapy, for persistent insomnia in children with autism spectrum disorders: a randomized placebo-controlled trial.
    Cortesi F, Giannotti F, Sebastiani T, Panunzi S, Valente D.
    J Sleep Res; 2012 Dec 01; 21(6):700-9. PubMed ID: 22616853
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 19.